Rob Gundermann: PBMs are under a microscope and patients will benefit from changes

The column below reflects the views of the author, and these opinions are neither endorsed nor supported by WisOpinion.com.
Over the last few years, Wisconsin has been exploring what can be done at the state level to reduce prescription drug prices. In trying to reduce prices, Wisconsin leaders have correctly focused on the middlemen in the prescription drug market, pharmacy benefit managers or PB...

Please log in to access subscriber content.
If you don't have a subscription, please contact schmies@wispolitics.com for subscription options on the WisPolitics-State Affairs platform, which is the new home for WisPolitics subscriber products.
Facebook
X
LinkedIn

Upcoming Events